Texas A&M Veterinary Medical Diagnostic Laboratory

Texas A&M Veterinary Medical Diagnostic Laboratory, operating as Texas A&M Veterinary Medical Diagnostic Laboratory System and a division of the Texas A&M University System, is a state government entity and 1862 land grant college that provides high-consequence animal disease diagnostic testing and laboratory analysis to the U.S. Department of Agriculture as a prime contractor, with 98% of recent awards issued in the prime capacity and zero set-aside designations across the footprint.

The laboratory's customer base concentrates entirely within USDA. APHIS Veterinary Services dominates the customer roster with 69 awards carrying $22.7 million in combined potential value, while APHIS Marketing and Regulatory Programs Business Services accounts for 22 awards worth $21.4 million. The National Institute of Food and Agriculture funds 11 cooperative agreements focused on infrastructure and network capacity building. Across top customers by both award count and dollar value, USDA represents 97% of the combined potential value in the portfolio, with no meaningful customer diversification outside the department.

Texas A&M Veterinary Medical Diagnostic Laboratory holds a cornerstone $20 million single-award Indefinite Delivery Contract (12639521D0077) with APHIS Veterinary Services, awarded September 20, 2021, extending through August 31, 2026. This IDC has spawned 29 task orders carrying $2 million in combined potential value, covering firm fixed-price delivery orders for highly pathogenic avian influenza testing, low pathogenic avian influenza testing, classical swine fever and African swine fever diagnostic work, scrapie testing, anthrax and rabies analysis, New World screwworm identification, foreign animal disease screening, and antimicrobial resistance and susceptibility testing. Recent representative task orders under this vehicle include a $500,000 HPAI end-user testing delivery order issued July 13, 2026 (most recent award, with performance extending through July 12, 2027), a $300,000 HPAI testing order from March 2025, and a $100,000 HPAI testing delivery order from April 2025. The laboratory also places work under multiple legacy BPAs including AG6395B100019 (23 task orders, $823 thousand), AG6395B130098 (14 task orders, $880 thousand), and predecessor APHIS animal lab testing vehicles. Federal grant funding supports laboratory network infrastructure, with cooperative agreements from APHIS and the National Institute of Food and Agriculture totaling $399,834 (February 2026 CFDA 10.025 award for Influenza A Virus surge-testing capacity enhancement through January 2028), $199,984 (July 2024 for sample submission and accessioning process toolkit), $250,000 (September 2023 Food and Agriculture Defense Initiative award), and multiple annual infrastructure support agreements ranging from $100,000 to $250,000 for quality systems, laboratory information management systems, and workforce development within the National Animal Health Laboratory Network.

Activity has remained steady across the past five years — five awards in 2022, nine in 2023, fourteen in 2024, eight in 2025, and five awarded through mid-2026 — with 14 awards carrying combined potential value of $1.2 million reaching completion inside the next twenty-four months, exposing the vendor to recompete risk on that dollar volume. The laboratory operates facilities in College Station, Texas and Ames, Iowa, performing diagnostic testing for high-consequence diseases including avian influenza variants, swine fever, scrapie, anthrax, rabies, screwworm, and antimicrobial resistance. The subcontract footprint is negligible (2% of awards); one grant sub-award with Texas Parks and Wildlife Department for chronic wasting disease sample testing and analysis was issued November 2025. TVMDL is a child entity within the Texas A&M University System, the parent 1862 land grant institution headquartered in College Station, Texas.